MiddleBrook Pharmaceuticals, Inc. (MBRK) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 111 transactions totaling $1.1M, demonstrating a bullish sentiment with $531.8K in net insider flow. The most recent transaction on Nov 22, 2010 involved a transaction of 32,303,030 shares valued at $0.
No significant insider buying has been recorded for MBRK in the recent period.
No significant insider selling has been recorded for MBRK in the recent period.
Based on recent SEC filings, insider sentiment for MBRK is bullish with an Insider Alignment Score of 73/100 and a net flow of $531.8K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at MiddleBrook Pharmaceuticals, Inc. (MBRK) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading MBRK stock, having executed 111 transactions in the past 90 days. The most active insider is L.l.c. Egi-mbrk, (Executive), who has made 1 transactions totaling $840.0K.
Get notified when executives and directors at MBRK file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 22, 2010 | Llc Sz Investments | Executive | Other | 32,303,030 | $N/A | $0 | |
| Nov 22, 2010 | Llc Sz Investments | Executive | Other | 19,022,726 | $N/A | $0 | |
| Dec 17, 2009 | Egi-mbrk, L.l.c. | Executive | Purchase | 2,000,000 | $0.42 | $840.0K | Large |
| Mar 12, 2009 | L. Miller Timothy | Executive | Award | 22,500 | $1.43 | $32.2K | |
| Sep 12, 2008 | Cole Brad | Executive | Award | 1,700 | $1.60 | $2.7K | |
| Sep 12, 2008 | Cole Brad | Executive | Award | 200 | $1.60 | $320 | |
| Sep 12, 2008 | Cole Brad | Executive | Award | 8,100 | $1.60 | $13.0K | |
| Nov 26, 2007 | M. Rudnic Edward | Executive | Sale | 6,585 | $1.10 | $7.2K | |
| Nov 26, 2007 | M. Rudnic Edward | Executive | Sale | 1,415 | $1.11 | $1.6K | |
| Nov 26, 2007 | M. Rudnic Edward | Executive | Sale | 3,100 | $1.12 | $3.5K | |
| Nov 26, 2007 | M. Rudnic Edward | Executive | Sale | 300 | $1.09 | $327 | |
| Nov 23, 2007 | M. Rudnic Edward | Executive | Sale | 200 | $1.04 | $208 | |
| Nov 23, 2007 | M. Rudnic Edward | Executive | Sale | 2,200 | $1.05 | $2.3K | |
| Nov 21, 2007 | M. Rudnic Edward | Executive | Sale | 3,000 | $1.08 | $3.2K | |
| Nov 21, 2007 | M. Rudnic Edward | Executive | Sale | 1,300 | $1.10 | $1.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 1 | $840.0K | 70.2% |
Sale(S) | 104 | $308.2K | 25.8% |
Award(A) | 4 | $48.2K | 4.0% |
Other(J) | 2 | $0 | 0.0% |
Insiders at MiddleBrook Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 5 insiders making 111 transactions totaling $840.0K in purchases versus $308.2K in sales, the net buying activity of $531.8K signals strong executive confidence. L.l.c. Egi-mbrk, (Executive) leads the buying activity with $840.0K in transactions across all time.